Lantern Pharma Inc (LTRN)

Finanzdaten der Lantern Pharma Inc-Aktie (LTRN)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-07-01
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	3.02%3.51	3.41	4.20	4.35	4.65
Research and Development	3.83%1.79	1.72	2.74	2.44	3.07
Depreciation and Amortization	2.65%0.00	0.00	0.00	0.00	0.00
Operating Income/Loss	3.02%-3.51	-3.41	-4.20	-4.35	-4.65
	112.43%-7.07	-3.33	-4.07	-4.18	-4.33
Attributable To Parent	112.43%-7.07	-3.33	-4.07	-4.18	-4.33
Basic Average Shares	10.40%12.42	11.25	-	10.83	10.78
Diluted Average Shares	10.40%12.42	11.25	-	10.83	10.78
Basic Earnings Per Share	90.00%-0.57	-0.30	-	-0.39	-0.40
Diluted Earnings Per Share	90.00%-0.57	-0.30	-	-0.39	-0.40